The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cancer in Transgender People: Evidence and Methodological Considerations
Open accessAbstract
Transgender people comprise a diverse group of individuals whose gender identity or expression differs from that originally assigned to them at birth. Some, but not all, transgender people elect to undergo medical gender affirmation, which may include therapy with cross-sex hormones and/or surgical change of the genitalia and other sex characteristics. As cross-sex hormones administered for the purposes of gender affirmation may be delivered at high doses and over a period of decades, the carcinogenicity of hormonal therapy in transgender people is an area of considerable concern. In addition, concerns about cancer risk in transgender patients have been linked to sexually transmitted infections, increased exposure to well-known risk factors such as smoking and alcohol use, and the lack of adequate access to screening. Several publications have identified cancer as an important priority in transgender health research and called for large-scale studies. The goals of this article are to summarize the evidence on factors that may differentially affect cancer risk in transgender people, assess the relevant cancer surveillance and epidemiologic data available to date, and offer an overview of possible methodological considerations for future studies investigating cancer incidence and mortality in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Physical and Mental Health of Transgender Older Adults: An At-Risk and Underserved Population
Fredriksen-Goldsen, K. I., Cook-Daniels, L., Kim, H.-J., Erosheva, E. A., Emlet, C. A., Hoy-Ellis, C. P., Goldsen, J., & Muraco, A. (2014) · The Gerontologist · doi:10.1093/geront/gnt021 · Cited by 582
Pap test use is lower among female-to-male patients than non-transgender women.
Peitzmeier, S. M., Khullar, K., Reisner, S. L., & Potter, J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.07.031 · Cited by 212
Prevalence of neovaginal high-risk human papillomavirus among transgender women in the Netherlands.
van der Sluis, W. B., Buncamper, M. E., Bouman, M.-B., Elfering, L., Özer, M., Bogaarts, M., Steenbergen, R. D. M., Heideman, D. A. M., & Mullender, M. G. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000476 · Cited by 37
Ito, K., Miki, Y., Suzuki, T., McNamara, K. M., & Sasano, H. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0470 · Cited by 29
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Self-citationde Blok, C. J. M., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M. A., Barbé, E., Konings, I. R. H. M., & den Heijer, M. (2019) · BMJ · doi:10.1136/bmj.l1652 · Cited by 366
Endocrinology of Transgender Medicine
T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00011 · Cited by 314
Self-citationAlpert, A. B., Gampa, V., Lytle, M. C., Manzano, C., Ruddick, R., Poteat, T., Quinn, G. P., & Kamen, C. S. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.03.007 · Cited by 73
Boehmer, U., Jesdale, B. M., Streed, C. G., & Agénor, M. (2022) · Cancer · doi:10.1002/cncr.33915 · Cited by 38
Metadata
- Authors
- Braun, H., Nash, R., Tangpricha, V., Brockman, J., Ward, K., & Goodman, M.
- Venue
- Epidemiologic Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-01
- Volume
- 39
- Issue
- 1
- Pages
- 93-107
- ISSN
- 0193-936X (ISSN-L)
- 1478-6729
- OpenAlex
- W2614036337
- Cited by
- 208
- References
- 5
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer in Transgender People: Evidence and Methodological Considerations. https://app.cochat.ai/papers/10.1093/epirev/mxw003
- The paper
- Braun, H., Nash, R., Tangpricha, V., Brockman, J., Ward, K., & Goodman, M. (2017). Cancer in Transgender People: Evidence and Methodological Considerations. Epidemiologic Reviews. https://doi.org/10.1093/epirev/mxw003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.